IBRX
Price
$2.69
Change
-$0.00 (-0.00%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
2.37B
14 days until earnings call
SAVA
Price
$1.66
Change
-$0.01 (-0.60%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
80.19M
14 days until earnings call
Ad is loading...

IBRX vs SAVA

Header iconIBRX vs SAVA Comparison
Open Charts IBRX vs SAVABanner chart's image
ImmunityBio
Price$2.69
Change-$0.00 (-0.00%)
Volume$49.42K
Capitalization2.37B
Cassava Sciences
Price$1.66
Change-$0.01 (-0.60%)
Volume$8.4K
Capitalization80.19M
IBRX vs SAVA Comparison Chart
Loading...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IBRX vs. SAVA commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBRX is a StrongBuy and SAVA is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (IBRX: $2.68 vs. SAVA: $1.66)
Brand notoriety: IBRX and SAVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IBRX: 82% vs. SAVA: 64%
Market capitalization -- IBRX: $2.37B vs. SAVA: $80.19M
IBRX [@Biotechnology] is valued at $2.37B. SAVA’s [@Biotechnology] market capitalization is $80.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IBRX’s FA Score shows that 1 FA rating(s) are green whileSAVA’s FA Score has 1 green FA rating(s).

  • IBRX’s FA Score: 1 green, 4 red.
  • SAVA’s FA Score: 1 green, 4 red.
According to our system of comparison, both IBRX and SAVA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IBRX’s TA Score shows that 5 TA indicator(s) are bullish while SAVA’s TA Score has 4 bullish TA indicator(s).

  • IBRX’s TA Score: 5 bullish, 3 bearish.
  • SAVA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IBRX is a better buy in the short-term than SAVA.

Price Growth

IBRX (@Biotechnology) experienced а +8.06% price change this week, while SAVA (@Biotechnology) price change was +18.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

IBRX is expected to report earnings on Aug 06, 2025.

SAVA is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IBRX($2.37B) has a higher market cap than SAVA($80.2M). IBRX YTD gains are higher at: 4.688 vs. SAVA (-29.661). SAVA has higher annual earnings (EBITDA): -141.15M vs. IBRX (-264.43M). IBRX has more cash in the bank: 150M vs. SAVA (129M). SAVA has less debt than IBRX: SAVA (0) vs IBRX (504M). IBRX has higher revenues than SAVA: IBRX (14.7M) vs SAVA (0).
IBRXSAVAIBRX / SAVA
Capitalization2.37B80.2M2,960%
EBITDA-264.43M-141.15M187%
Gain YTD4.688-29.661-16%
P/E RatioN/AN/A-
Revenue14.7M0-
Total Cash150M129M116%
Total Debt504M0-
FUNDAMENTALS RATINGS
IBRX vs SAVA: Fundamental Ratings
IBRX
SAVA
OUTLOOK RATING
1..100
603
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10091
PRICE GROWTH RATING
1..100
8097
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IBRX's Valuation (3) in the Biotechnology industry is in the same range as SAVA (23) in the Pharmaceuticals Other industry. This means that IBRX’s stock grew similarly to SAVA’s over the last 12 months.

IBRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SAVA (100) in the Pharmaceuticals Other industry. This means that IBRX’s stock grew similarly to SAVA’s over the last 12 months.

SAVA's SMR Rating (91) in the Pharmaceuticals Other industry is in the same range as IBRX (100) in the Biotechnology industry. This means that SAVA’s stock grew similarly to IBRX’s over the last 12 months.

IBRX's Price Growth Rating (80) in the Biotechnology industry is in the same range as SAVA (97) in the Pharmaceuticals Other industry. This means that IBRX’s stock grew similarly to SAVA’s over the last 12 months.

IBRX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as SAVA (100) in the Pharmaceuticals Other industry. This means that IBRX’s stock grew similarly to SAVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IBRXSAVA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 24 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VUZI1.710.05
+3.01%
Vuzix Corp
SWGAY8.520.09
+1.07%
Swatch Group AG
BDVSY24.680.16
+0.65%
Bidvest Group Ltd.
BDCO1.68N/A
N/A
Blue Dolphin Energy Co.
NRDBY13.22-0.03
-0.23%
Nordea Bank Abp

SAVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SAVA has been loosely correlated with CRSP. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SAVA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAVA
1D Price
Change %
SAVA100%
+4.40%
CRSP - SAVA
35%
Loosely correlated
-1.76%
IBRX - SAVA
29%
Poorly correlated
-0.37%
LXRX - SAVA
26%
Poorly correlated
+5.38%
AMRN - SAVA
26%
Poorly correlated
-1.24%
VKTX - SAVA
26%
Poorly correlated
+1.22%
More